AcouSort AB (ACOU.ST)
AcouSort AB operates in the Medical - Distribution industry of the Healthcare sector, headquartered in Lund, SN, SE. The stock last traded at $2.85, down 0.70% on the session, giving a market capitalisation of $60.3M. Its beta of 0.10 implies it has historically moved less than the broad market.
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy and other elements of the future automated systems. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden.
AcouSort AB is most often compared with the following Healthcare names: